Developer docs
API playgroundTry for free, no card

Search company profiles

Basepaws

Full company profile

uuid0000v55

Namestring
Basepaws
Legal namestring
Basepaws Inc.
Websiteurl
basepaws.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Basepaws is a US-based pet genetics company founded in 2017 that develops and sells at-home DNA testing kits for cats and dogs, providing breed identification, genetic health risk screening, trait analysis, and oral microbiome assessment. The company's core technology uses Next-Generation Sequencing (NGS), including a premium Whole Genome Sequencing tier that decodes 100% of the cat genome at 15x coverage with raw FASTQ and VCF data outputs. The proprietary Feline Oral Microbiome Analysis screens 600+ microbes for signatures of periodontal disease, tooth resorption, and halitosis. Basepaws operates a direct-to-consumer e-commerce model selling one-time test kits priced from $79.99 to $499 through basepaws.com, supplemented by a community-led citizen science program that builds the company's proprietary feline genomic and oral microbiome database.

In 2022, Basepaws was acquired by Zoetis, the world's leading animal health company, for at least $50 million, with the company now operating as a wholly-owned subsidiary and leveraging Zoetis's veterinary distribution, R&D, and precision medicine infrastructure. The customer base is highly fragmented across individual pet parents, with secondary reach into veterinary professionals via a dedicated vet portal. Pricing ranges from $79.99 for the Breed + Health Dog DNA Test to $499 for Whole Genome Sequencing, with optional pay-in-4 and affirm financing for higher-priced orders. The company maintains 11-50 employees with headquarters in El Segundo (website presence) and a legal address at Zoetis c/o Basepaws in Kalamazoo, Michigan, and operates across North America with international shipping available.

Short descriptiontext

Basepaws is a US-based pet genetics company founded in 2017 that sells at-home DNA testing kits for cats and dogs using Next-Generation Sequencing technology to provide breed identification, health risk screening, and oral microbiome analysis to individual pet parents, operating as a wholly-owned subsidiary of Zoetis since 2022.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTorrance, United States
HQ citystring
Torrance
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pet DNA testing, cat genetic test, dog DNA test, oral microbiome test, whole genome sequencing
Industry3 codes
PRIMARYHLAMADAE
Molecular & Genetic Testing (Breed, Hereditary Disease, Oncology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAMAFAI
Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Medical Devices & Supplies
SECONDARYHLAMADAC
Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
NAICS code1 code
  • Medical Laboratories621511
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
Product category
Pet Genetic Testing
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Direct-to-Consumer DNA Test Kits
TypeOne Time License
Description

One-time product sales of at-home pet DNA testing kits sold directly to consumers through e-commerce. Products include Breed + Health Cat DNA Test, Dog DNA Test, Oral Health Test for Cats, and Whole Genome Sequencing. Revenue is generated per test kit with no subscription requirement, though Whole Genome Sequencing includes free lifetime report updates.

basepaws.com
2Optional Financing
TypeTransaction Fee
Description

Pay-in-4 interest-free installments offered for orders over $50, and monthly payment plans through third-party financing (affirm). This extends accessibility to higher-priced products like Whole Genome Sequencing at $499.

basepaws.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details4 tiers
1Breed + Health Cat DNA Test - $99.99 (regularly $159.00)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Includes 21 cat breeds, 64 genetic health markers, 50 genetic trait markers, oral health report, and blood type. Results in 4-6 weeks.

basepaws.com
2Breed + Health Dog DNA Test - $79.99 (regularly $149.00)
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Includes 330+ breeds, 280+ health markers, 30+ trait markers. Results in 4-6 weeks.

basepaws.com
3Whole Genome Sequencing for Cats - $499.00
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Includes everything in Breed + Health plus 100% DNA decoded, raw data files (FASTQ/VCF), and free lifetime report updates as database grows. Results in 9-12 weeks.

basepaws.com
4Oral Health Test for Cats - $99.00
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Screens for 600+ microbes to detect risk for periodontal disease, tooth resorption, and halitosis. Includes personalized clinical care recommendations. Multiple test bundles available (2 tests for $179, 4 tests for $316).

basepaws.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Basepaws sells at-home DNA testing kits for cats and dogs that use cheek-swab sample collection and Next-Generation Sequencing laboratory analysis to deliver personalized digital reports covering breed composition, genetic health risk markers, trait markers, and oral microbiome disease signatures. Its product line includes the Breed + Health Cat DNA Test, Breed + Health Dog DNA Test, a standalone Oral Health Test for Cats, and a premium Whole Genome Sequencing product for cats.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 70% of adult cats have dental health problems - early detection enables proactive intervention
+2 more records
Product overview1 text field

Basepaws offers an integrated portfolio of at-home pet health genetic testing products for cats and dogs. The core offerings include the Breed + Health DNA Tests (for both cats and dogs) which provide breed identification, genetic health screening, and trait analysis. The Cat DNA Test screens for 21 cat breeds, 64 health markers, and 50 trait markers with an included oral health report; the Dog DNA Test covers 330+ breeds, 280+ health markers, and 30+ trait markers. Premium add-ons include the Oral Health Test for Cats (standalone oral microbiome screening) and Whole Genome Sequencing for Cats (comprehensive 100% genome decoding with raw data files and lifetime updates). All tests use cheek swab sample collection with results delivered digitally within 4-12 weeks.

Product and service5 records
1Breed + Health Cat DNA Test
CategoryAt-home cat DNA test kit
Description

At-home DNA test for cats that identifies 21 cat breeds, screens for 64 genetic health markers and 50 genetic trait markers, includes an oral health report and blood type, with digital results delivered in 4-6 weeks.

2Breed + Health Dog DNA Test
CategoryAt-home dog DNA test kit
Description

At-home DNA test for dogs providing breed composition analysis across 330+ breeds, screening for 280+ health markers and 30+ trait markers using Next-Generation Sequencing, with results delivered digitally in 4-6 weeks.

3Oral Health Test for Cats
CategoryAt-home cat oral microbiome test
Description

Standalone at-home oral microbiome test for cats that screens 600+ microbes for risk signatures associated with periodontal disease, tooth resorption, and halitosis, and provides risk scores plus personalized clinical care and at-home care recommendations.

4Whole Genome Sequencing for Cats
CategoryPremium whole genome sequencing service
Description

Premium DNA sequencing service decoding 100% of a cat's genome at 15x coverage, producing 10,000x more data than standard DNA microarrays; includes everything in the Breed + Health test plus raw FASTQ/VCF data files and free lifetime report updates, with results in 9-12 weeks.

5Dog Fitness Program
CategoryFree educational email program
Description

Free 3-part email-based fitness program that delivers personalized exercise plans tailored to a dog's DNA profile, breed-specific workouts, and guidance on how genetics influence exercise requirements.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Embark is the leading direct-to-consumer dog and cat DNA testing company, using genotyping and breed identification. It is the most direct competitor to Basepaws in the pet genetic testing space, with overlapping product offerings (breed, health, and trait tests) and similar NGS-based technology approach.

TypeDirect peer
Description

Wisdom Panel, owned by Mars Petcare, is a major pet genetic testing brand offering breed identification and health screening for both dogs and cats. It is one of the largest competitors in the DTC pet DNA market with broad retail distribution through pet stores and veterinary channels.

TypeDirect peer
Description

DNA My Dog offers breed identification and genetic testing for dogs at lower price points. While less scientifically comprehensive than Basepaws' offerings, it competes for price-sensitive pet parents in the same DTC genetic testing category.

TypeDirect peer
Description

Orivet provides genetic testing for dogs and cats with a focus on breed identification, health screening, and personalized wellness plans. It serves both pet owners and veterinary professionals, overlapping with Basepaws' vet and consumer channels.

TypeDirect peer
Description

Paw Print Genetics specializes in genetic testing for hereditary diseases in dogs and cats. It is more clinically-oriented than Basepaws but overlaps in the disease screening and genetic health marker testing space.

TypeBroad incumbent
Description

Zoetis is the parent company of Basepaws and the world's leading animal health company. It offers diagnostics, vaccines, and pharmaceuticals across the veterinary sector, providing Basepaws access to a global distribution network and clinical research infrastructure.

TypeBroad incumbent
Description

IDEXX is a dominant veterinary diagnostics company offering in-clinic lab tests, reference lab services, and imaging for companion animals. As a broad incumbent, it competes indirectly with Basepaws in the pet health diagnostics space and represents a potential acquirer or strategic partner.

TypeBroad incumbent
Description

Antech Diagnostics (owned by Mars) provides veterinary reference lab services, imaging, and diagnostic testing across the U.S. It is a broad incumbent in veterinary diagnostics with deeper vet-channel distribution than Basepaws.

TypeEmerging player
Description

PetDx focuses on liquid biopsy and genomic testing for cancer detection in dogs. While focused on oncology rather than breed/trait testing, it overlaps with Basepaws in applying NGS technology to companion animal health.

TypeOthers
Description

Royal Canin, owned by Mars Petcare, produces breed-specific and health-targeted pet foods. Basepaws' data could be integrated into breed-specific nutrition products via its parent Zoetis, making Royal Canin a comparable thematically adjacent player in personalized pet nutrition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Basepaws

Pet Genetic Testingbasepaws.com

Basepaws is a US-based pet genetics company founded in 2017 that sells at-home DNA testing kits for cats and dogs using Next-Generation Sequencing technology to provide breed identification, health risk screening, and oral microbiome analysis to individual pet parents, operating as a wholly-owned subsidiary of Zoetis since 2022.

What Basepaws does

Basepaws is a US-based pet genetics company founded in 2017 that develops and sells at-home DNA testing kits for cats and dogs, providing breed identification, genetic health risk screening, trait analysis, and oral microbiome assessment. The company's core technology uses Next-Generation Sequencing (NGS), including a premium Whole Genome Sequencing tier that decodes 100% of the cat genome at 15x coverage with raw FASTQ and VCF data outputs. The proprietary Feline Oral Microbiome Analysis screens 600+ microbes for signatures of periodontal disease, tooth resorption, and halitosis. Basepaws operates a direct-to-consumer e-commerce model selling one-time test kits priced from $79.99 to $499 through basepaws.com, supplemented by a community-led citizen science program that builds the company's proprietary feline genomic and oral microbiome database.

In 2022, Basepaws was acquired by Zoetis, the world's leading animal health company, for at least $50 million, with the company now operating as a wholly-owned subsidiary and leveraging Zoetis's veterinary distribution, R&D, and precision medicine infrastructure. The customer base is highly fragmented across individual pet parents, with secondary reach into veterinary professionals via a dedicated vet portal. Pricing ranges from $79.99 for the Breed + Health Dog DNA Test to $499 for Whole Genome Sequencing, with optional pay-in-4 and affirm financing for higher-priced orders. The company maintains 11-50 employees with headquarters in El Segundo (website presence) and a legal address at Zoetis c/o Basepaws in Kalamazoo, Michigan, and operates across North America with international shipping available.

Basepaws firmographics

Firmographics
Name
Basepaws
Legal name
Basepaws Inc.
Website
https://basepaws.com
Company type
Private
Founded year
2017
Operating status
Acquired
Headcount range
11–50 employees
Short description
Basepaws is a US-based pet genetics company founded in 2017 that sells at-home DNA testing kits for cats and dogs using Next-Generation Sequencing technology to provide breed identification, health risk screening, and oral microbiome analysis to individual pet parents, operating as a wholly-owned subsidiary of Zoetis since 2022.
Ownership category
akta.pro rank

Basepaws industry classification

Industry
Product category
Pet Genetic Testing
NAICS
Medical Laboratories (621511)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAMADAE
Molecular & Genetic Testing (Breed, Hereditary Disease, Oncology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)
SECONDARYHLAMAFAI
Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Medical Devices & Supplies
SECONDARYHLAMADAC
Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Diagnostics (Labs & Imaging)

Keywords

  • Pet DNA testing
  • Cat genetic test
  • Dog DNA test
  • Oral microbiome test
  • Whole genome sequencing

Where Basepaws is headquartered

Location

Headquarters

HQ city
Torrance
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Basepaws business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Direct-to-Consumer DNA Test Kits: One-time product sales of at-home pet DNA testing kits sold directly to consumers through e-commerce. Products include Breed + Health Cat DNA Test, Dog DNA Test, Oral Health Test for Cats, and Whole Genome Sequencing. Revenue is generated per test kit with no subscription requirement, though Whole Genome Sequencing includes free lifetime report updates.
  2. Optional Financing: Pay-in-4 interest-free installments offered for orders over $50, and monthly payment plans through third-party financing (affirm). This extends accessibility to higher-priced products like Whole Genome Sequencing at $499.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goBreed + Health Cat DNA Test - $99.99 (regularly $159.00)
One time/ perpetual licensePay-as-you-goBreed + Health Dog DNA Test - $79.99 (regularly $149.00)
One time/ perpetual licensePay-as-you-goWhole Genome Sequencing for Cats - $499.00
One time/ perpetual licensePay-as-you-goOral Health Test for Cats - $99.00

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Basepaws product offering

Product offering

Core offering

Basepaws sells at-home DNA testing kits for cats and dogs that use cheek-swab sample collection and Next-Generation Sequencing laboratory analysis to deliver personalized digital reports covering breed composition, genetic health risk markers, trait markers, and oral microbiome disease signatures. Its product line includes the Breed + Health Cat DNA Test, Breed + Health Dog DNA Test, a standalone Oral Health Test for Cats, and a premium Whole Genome Sequencing product for cats.

Product overview

Basepaws offers an integrated portfolio of at-home pet health genetic testing products for cats and dogs. The core offerings include the Breed + Health DNA Tests (for both cats and dogs) which provide breed identification, genetic health screening, and trait analysis. The Cat DNA Test screens for 21 cat breeds, 64 health markers, and 50 trait markers with an included oral health report; the Dog DNA Test covers 330+ breeds, 280+ health markers, and 30+ trait markers. Premium add-ons include the Oral Health Test for Cats (standalone oral microbiome screening) and Whole Genome Sequencing for Cats (comprehensive 100% genome decoding with raw data files and lifetime updates). All tests use cheek swab sample collection with results delivered digitally within 4-12 weeks.

Differentiator

Problem solved

Functional benefit

Products and services

  • Breed + Health Cat DNA Test At-home DNA test for cats that identifies 21 cat breeds, screens for 64 genetic health markers and 50 genetic trait markers, includes an oral health report and blood type, with digital results delivered in 4-6 weeks.
  • Breed + Health Dog DNA Test At-home DNA test for dogs providing breed composition analysis across 330+ breeds, screening for 280+ health markers and 30+ trait markers using Next-Generation Sequencing, with results delivered digitally in 4-6 weeks.
  • Oral Health Test for Cats Standalone at-home oral microbiome test for cats that screens 600+ microbes for risk signatures associated with periodontal disease, tooth resorption, and halitosis, and provides risk scores plus personalized clinical care and at-home care recommendations.
  • Whole Genome Sequencing for Cats Premium DNA sequencing service decoding 100% of a cat's genome at 15x coverage, producing 10,000x more data than standard DNA microarrays; includes everything in the Breed + Health test plus raw FASTQ/VCF data files and free lifetime report updates, with results in 9-12 weeks.
  • Dog Fitness Program Free 3-part email-based fitness program that delivers personalized exercise plans tailored to a dog's DNA profile, breed-specific workouts, and guidance on how genetics influence exercise requirements.

Quantifiable outcome

  • 70% of adult cats have dental health problems - early detection enables proactive intervention
  • +2 more outcomes

Companies that use Basepaws

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Basepaws technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Basepaws partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Basepaws competitors and assessment

Company assessment

Direct peers

  • Embark Veterinary: Embark is the leading direct-to-consumer dog and cat DNA testing company, using genotyping and breed identification. It is the most direct competitor to Basepaws in the pet genetic testing space, with overlapping product offerings (breed, health, and trait tests) and similar NGS-based technology approach.
  • Wisdom Panel: Wisdom Panel, owned by Mars Petcare, is a major pet genetic testing brand offering breed identification and health screening for both dogs and cats. It is one of the largest competitors in the DTC pet DNA market with broad retail distribution through pet stores and veterinary channels.
  • DNA My Dog: DNA My Dog offers breed identification and genetic testing for dogs at lower price points. While less scientifically comprehensive than Basepaws' offerings, it competes for price-sensitive pet parents in the same DTC genetic testing category.
  • Orivet Genetic Pet Care: Orivet provides genetic testing for dogs and cats with a focus on breed identification, health screening, and personalized wellness plans. It serves both pet owners and veterinary professionals, overlapping with Basepaws' vet and consumer channels.
  • Paw Print Genetics: Paw Print Genetics specializes in genetic testing for hereditary diseases in dogs and cats. It is more clinically-oriented than Basepaws but overlaps in the disease screening and genetic health marker testing space.

Broad incumbents

  • Zoetis: Zoetis is the parent company of Basepaws and the world's leading animal health company. It offers diagnostics, vaccines, and pharmaceuticals across the veterinary sector, providing Basepaws access to a global distribution network and clinical research infrastructure.
  • IDEXX Laboratories: IDEXX is a dominant veterinary diagnostics company offering in-clinic lab tests, reference lab services, and imaging for companion animals. As a broad incumbent, it competes indirectly with Basepaws in the pet health diagnostics space and represents a potential acquirer or strategic partner.
  • Antech Diagnostics: Antech Diagnostics (owned by Mars) provides veterinary reference lab services, imaging, and diagnostic testing across the U.S. It is a broad incumbent in veterinary diagnostics with deeper vet-channel distribution than Basepaws.

Emerging players

  • PetDx: PetDx focuses on liquid biopsy and genomic testing for cancer detection in dogs. While focused on oncology rather than breed/trait testing, it overlaps with Basepaws in applying NGS technology to companion animal health.

Others

  • Royal Canin (Mars Petcare): Royal Canin, owned by Mars Petcare, produces breed-specific and health-targeted pet foods. Basepaws' data could be integrated into breed-specific nutrition products via its parent Zoetis, making Royal Canin a comparable thematically adjacent player in personalized pet nutrition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Basepaws social profiles

Digital presence

Basepaws financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Basepaws leadership team

Management profile

Number of profiles

Profiles6 records

Basepaws funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Basepaws M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Basepaws

What does Basepaws do?

Basepaws sells at-home DNA testing kits for cats and dogs that use cheek-swab sample collection and Next-Generation Sequencing laboratory analysis to deliver personalized digital reports covering breed composition, genetic health risk markers, trait markers, and oral microbiome disease signatures. Its product line includes the Breed + Health Cat DNA Test, Breed + Health Dog DNA Test, a standalone Oral Health Test for Cats, and a premium Whole Genome Sequencing product for cats.

Is Basepaws a public or private company?

Basepaws is a private company. It is classified as corporate owned and is currently acquired.

When was Basepaws founded?

Basepaws was founded in 2017. It employs 11 to 50 people.

Where is Basepaws based?

Basepaws is headquartered in Torrance, United States, in the North America region.

How does Basepaws make money?

Two revenue lines are on record. Direct-to-Consumer DNA Test Kits are the primary driver. The others are optional Financing.

Who are Basepaws's main competitors?

Direct peers on record are Embark Veterinary, Wisdom Panel, DNA My Dog, Orivet Genetic Pet Care and Paw Print Genetics. Broad incumbents are Zoetis, IDEXX Laboratories and Antech Diagnostics. PetDx is listed as an emerging player. Royal Canin (Mars Petcare) is listed as an others.

Does Basepaws have an API?

No public API is recorded for Basepaws.

What industry is Basepaws in?

Basepaws's product category is Pet Genetic Testing. Its primary akta.pro industry code is HLAMADAE, Molecular & Genetic Testing (Breed, Hereditary Disease, Oncology), with a secondary code of HLAMAFAI, Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy). Its NAICS code is 621511 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Refresh MiamiAnna Skaya built a pet genetics company. Now she’s funding pet startups and creating something new, this time in Miami.Anna Skaya, founder of Basepaws, launched Moisture Oyster, a pet eye-drop company, after finding poor-quality products in Miami. She also founded Ani.VC, a $35 million fund for pet startups, and expects US pet spending to reach $165 billion this year.WIREDWhat’s the Best Pet DNA Test? We Tested the Most Popular OnesWIRED tested three cat DNA kits—Basepaws, Koko Genetics, and Wisdom Panel—on two cats, finding Basepaws offered the most detailed health and oral health reports. Breed identification was unreliable for cats, and results should be shared with a veterinarian. The review also tested an allergy kit, which it found inaccurate.BenzingaKevin O’Leary Says Some ‘Shark Tank’ Investments Are ‘Turds’ And Some Are Hits — Nobody Wanted Cupcake-IKevin O'Leary recounted two Shark Tank investments that appeared unusual but delivered strong returns: Wicked Good Cupcakes, which he backed for $75,000 in a royalty deal and which was acquired by Hickory Farms in 2021, and Basepaws, a cat DNA testing company he invested in after being persuaded by founder Anna Skaya's conviction, which was later acquired by animal-health company Zoetis for over $50 million. O'Leary used these examples to illustrate that investors cannot always predict which seemingly odd ideas will succeed, emphasizing that execution ability and founder determination often matter more than the surface appeal of a product.EIN PresswireInfluential Women Podcast Features Anna Skaya, Founder of Basepaws & Managing Partner at AniVC, Reality of Solo FoundingAnna Skaya discussed her eight-year solo founding of Basepaws, the first cat DNA test, raising about $5 million and delivering a 25x return on early investment. She appeared on Shark Tank three times, closing on-camera deals with Kevin O'Leary and Robert Herjavec, and now serves as Managing Partner at AniVC.DVM 360Zoetis to acquire pet care genetics company BasepawsZoetis has announced its acquisition of pet care genetics company Basepaws, which provides comprehensive feline DNA testing and at-home oral microbiome assessments. Zoetis, a global animal health company, states that Basepaws' genomic and oral microbiome database will enhance its research and development capabilities in precision medicine. Financial terms of the agreement have not been disclosed.The Spruce PetsThe 4 Best Cat DNA Tests, Tested and ReviewedThe Spruce Pets reviewed and compared four cat DNA testing kits, identifying Wisdom Panel Complete as the best overall option due to its comprehensive health screening and large breed database. Basepaws was highlighted for its detailed genetic markers and oral health insights, while 5Strands was noted for rapid food intolerance testing. The review emphasizes that these tests are primarily advisory tools for pet owners.BenzingaKevin O'Leary's 'Basepaws' Bet Proves Small, Weird Investments Can Drive Big ReturnsKevin O'Leary invested in Basepaws, a cat DNA testing company founded by Anna Skaya, on Shark Tank after being persuaded by the estimated market of 110 million American cat owners. The company was acquired by animal-health giant Zoetis in 2022 for at least $50 million, with O'Leary's stake returning an estimated 20 to 35 times his initial investment, making it his most profitable Shark Tank deal in percentage terms. Zoetis was effectively acquiring Basepaws' proprietary feline genetics dataset to support development of pet drugs and foods.Shark Tank BlogThe Most Profitable Deal Ever Made on Shark TankBasePaws, a cat DNA testing company, appeared on Shark Tank Season 10 and secured a $250,000 investment from Kevin O'Leary and Robert Herjavec for a 10% equity stake. The company grew rapidly from approximately $200,000 in revenue within 10 months pre-Shark Tank to over $3.5 million in annual sales within two years after the episode aired. In mid-2022, BasePaws was acquired by Zoetis for over $50 million, representing one of the most profitable exits in Shark Tank history.ZoetisTransforming drug discovery and development with generative AIZoetis is integrating generative AI and advanced data analytics into its research and development processes to accelerate animal health drug discovery and improve clinical trial efficiency. The company is leveraging vast datasets, including genetic information from the Basepaws acquisition, and expanding its global R&D infrastructure to identify potential therapies more precisely. Zoetis aims to reduce failure rates in clinical trials and shorten the timeline from discovery to product launch through these technological investments.BenzingaKevin O'Leary Paid A Woman On 'Shark Tank' $250K To 'Get Her Out Of Here,' Then Made Millions Off Idea HeKevin O'Leary recounted a past investment where he paid $250,000 for a stake in Basepaws, a company founded by Anna Skaya that offers genetic testing for cats. He later sold the company to Zoetis for over $50 million, making a significant profit. The deal followed a failed pitch on 'Shark Tank' in 2019, which he initially mocked.